Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
8897.T Stock Summary
Top 10 Correlated ETFs
8897.T
In the News
8897.T Financial details
Company Rating
Strong Buy
Market Cap
47.55B
Income
4.21B
Revenue
157.78B
Book val./share
540.83
Cash/share
363.28
Dividend
6
Dividend %
1.38%
Employees
1.2K
Optionable
No
Shortable
Yes
Earnings
27 Jul 2023
P/E
11.3
Forward P/E
-
PEG
-10.73
P/S
0.3
P/B
0.81
P/C
1.2
P/FCF
-
Quick Ratio
0.33
Current Ratio
1.51
Debt / Equity
3.99
LT Debt / Equity
2.4
-
-
EPS (TTM)
38.67
EPS next Y
-
EPS next Q
-
EPS this Y
32.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.47%
Revenue last 5Y
7.98%
Revenue Q/Q
-52.13%
EPS Q/Q
-147.94%
-
-
-
-
SMA20
10.29%
SMA50
12.22%
SMA100
15.16%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
7%
ROC
0.04%
Gross Margin
20%
Oper. Margin
5%
Profit Margin
3%
Payout
-
Shs Outstand
109.05M
Shs Float
81.48M
-
-
-
-
Target Price
-
52W Range
327.0-440.0
52W High
-1.14%
52W Low
+33.03%
RSI
66.96
Rel Volume
1.15
Avg Volume
360.49K
Volume
415.7K
Perf Week
4.32%
Perf Month
14.78%
Perf Quarter
15.08%
Perf Half Y
13.87%
-
-
-
-
Beta
0.474274
-
-
Volatility
6.73%, 18.74%
Prev Close
1.64%
Price
435
Change
0.69%
8897.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 1.02K | 1.22K | 1.55K | 1.37K | 1.5K | |
Net income per share | 68.12 | 59.32 | 49.45 | 43.22 | 57.09 | |
Operating cash flow per share | 91.25 | 207.05 | 440.06 | 242.47 | 213.03 | |
Free cash flow per share | -188.68 | -74.69 | 168.14 | 4.28 | -22.92 | |
Cash per share | 270.2 | 195.39 | 325.71 | 360.7 | 307.09 | |
Book value per share | 396.7 | 438.84 | 469.27 | 500.88 | 544.82 | |
Tangible book value per share | 379.95 | 423.64 | 455.19 | 488.34 | 524.46 | |
Share holders equity per share | 396.7 | 438.84 | 469.27 | 500.88 | 544.82 | |
Interest debt per share | 996.05 | 1.04K | 1.06K | 1.1K | 1.19K | |
Market cap | 49.75B | 38.02B | 37.84B | 40.5B | 32.55B | |
Enterprise value | 127.19B | 128.67B | 116.56B | 119.9B | 127.09B | |
P/E ratio | 6.75 | 5.92 | 7.06 | 8.63 | 5.24 | |
Price to sales ratio | 0.45 | 0.29 | 0.22 | 0.27 | 0.2 | |
POCF ratio | 5.04 | 1.7 | 0.79 | 1.54 | 1.4 | |
PFCF ratio | -2.44 | -4.7 | 2.08 | 87.11 | -13.05 | |
P/B Ratio | 1.16 | 0.8 | 0.74 | 0.74 | 0.55 | |
PTB ratio | 1.16 | 0.8 | 0.74 | 0.74 | 0.55 | |
EV to sales | 1.15 | 0.97 | 0.69 | 0.81 | 0.78 | |
Enterprise value over EBITDA | 9.08 | 9.93 | 7.98 | 9.09 | 8.37 | |
EV to operating cash flow | 12.89 | 5.74 | 2.44 | 4.55 | 5.48 | |
EV to free cash flow | -6.23 | -15.91 | 6.39 | 257.86 | -50.94 | |
Earnings yield | 0.15 | 0.17 | 0.14 | 0.12 | 0.19 | |
Free cash flow yield | -0.41 | -0.21 | 0.48 | 0.01 | -0.08 | |
Debt to equity | 2.49 | 2.35 | 2.24 | 2.18 | 2.16 | |
Debt to assets | 0.6 | 0.6 | 0.58 | 0.58 | 0.57 | |
Net debt to EBITDA | 5.53 | 6.99 | 5.39 | 6.02 | 6.23 | |
Current ratio | 1.82 | 1.68 | 1.76 | 2.26 | 1.9 | |
Interest coverage | 11.81 | 9.11 | 10.38 | 8.8 | 6.77 | |
Income quality | 1.34 | 3.49 | 5.09 | 3.67 | 2.45 | |
Dividend Yield | 0.03 | 0.05 | 0.05 | 0.05 | 0.05 | |
Payout ratio | 0.22 | 0.27 | 0.34 | 0.39 | 0.24 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -3.07 | -1.36 | -0.62 | -0.98 | -1.11 | |
Capex to revenue | -0.27 | -0.23 | -0.17 | -0.17 | -0.16 | |
Capex to depreciation | -14.29 | -11.4 | -13.01 | -12.7 | -8.11 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 779.73 | 765.35 | 722.59 | 697.89 | 836.6 | |
ROIC | 0.08 | 0.05 | 0.06 | 0.06 | 0.06 | |
Return on tangible assets | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | |
Graham Net | -661.55 | -751.42 | -680.91 | -681.4 | -777.3 | |
Working capital | 46.62B | 39.97B | 49.7B | 70.04B | 67.62B | |
Tangible asset value | 41.09B | 45.89B | 49.35B | 53.03B | 57.09B | |
Net current asset value | -31.57B | -38.65B | -29B | -24B | -21.25B | |
Invested capital | 2.49 | 2.35 | 2.24 | 2.18 | 2.16 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 13.98B | 11.79B | 9.82B | 12.59B | 14.36B | |
Average inventory | 59.27B | 68.9B | 69.78B | 71.7B | 82.35B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 67.73 | 27.05 | 31.37 | 41.03 | 43.39 | |
Days of inventory on hand | 294.31 | 240.28 | 186.13 | 225.05 | 258.11 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 5.39 | 13.49 | 11.64 | 8.9 | 8.41 | |
Inventory turnover | 1.24 | 1.52 | 1.96 | 1.62 | 1.41 | |
ROE | 0.17 | 0.14 | 0.11 | 0.09 | 0.1 | |
Capex per share | -279.93 | -281.74 | -271.93 | -238.19 | -235.95 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 459.66 | 577.07 | 259.74 | 413.99 | 198.16 | |
Net income per share | 35.42 | 24.04 | 1.89 | 24.47 | -11.73 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 339.93 | 307.65 | 289.41 | 388.04 | 363.28 | |
Book value per share | 518.1 | 545.82 | 530.99 | 558.75 | 540.83 | |
Tangible book value per share | 491.09 | 525.42 | 510.16 | 538.39 | 448.4 | |
Share holders equity per share | 518.1 | 545.82 | 530.99 | 558.75 | 540.83 | |
Interest debt per share | 1.29K | 1.18K | 1.41K | 1.45K | 2.16K | |
Market cap | 31.4B | 32.49B | 39.26B | 41.98B | 40.35B | |
Enterprise value | 133.74B | 127.03B | 160.98B | 157.79B | 236.34B | |
P/E ratio | 2.04 | 3.11 | 47.64 | 3.93 | -7.89 | |
Price to sales ratio | 0.63 | 0.52 | 1.39 | 0.93 | 1.87 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.56 | 0.55 | 0.68 | 0.69 | 0.68 | |
PTB ratio | 0.56 | 0.55 | 0.68 | 0.69 | 0.68 | |
EV to sales | 2.68 | 2.03 | 5.68 | 3.5 | 10.94 | |
Enterprise value over EBITDA | 22.69 | 23.46 | 212.38 | 41.49 | -147.44 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.12 | 0.08 | 0.01 | 0.06 | -0.03 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 2.47 | 2.16 | 2.65 | 2.6 | 3.99 | |
Debt to assets | 0.61 | 0.57 | 0.63 | 0.63 | 0.72 | |
Net debt to EBITDA | 17.36 | 17.46 | 160.58 | 30.45 | -122.27 | |
Current ratio | 2.07 | 1.9 | 1.98 | 2.05 | 1.51 | |
Interest coverage | 11.45 | 16.01 | 1.66 | 9.54 | -4.52 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 642.61 | 543.35 | 150.23 | 554.7 | 377.78 | |
ROIC | 0.03 | 0.02 | 0 | 0.02 | -0.01 | |
Return on tangible assets | 0.02 | 0.01 | 0 | 0.01 | 0 | |
Graham Net | -767.19 | -778.73 | -880.21 | -833.27 | -1.49K | |
Working capital | 79.76B | 67.62B | 82.04B | 88.49B | 61.5B | |
Tangible asset value | 53.36B | 57.09B | 55.63B | 58.71B | 48.9B | |
Net current asset value | -16B | -21.25B | -19.54B | -18.13B | -83.22B | |
Invested capital | 2.47 | 2.16 | 2.65 | 2.6 | 3.99 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 8.33B | 12.43B | 13.95B | 11.53B | 9.06B | |
Average inventory | 105.56B | 96.1B | 103.74B | 115.41B | 120.98B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 21.81 | 27.22 | 49.99 | 26.54 | 39.11 | |
Days of inventory on hand | 232.12 | 161.9 | 463.54 | 288.77 | 657.41 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 4.13 | 3.31 | 1.8 | 3.39 | 2.3 | |
Inventory turnover | 0.39 | 0.56 | 0.19 | 0.31 | 0.14 | |
ROE | 0.07 | 0.04 | 0 | 0.04 | -0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
8897.T Frequently Asked Questions
What is Takara Leben Co., Ltd. stock symbol ?
Takara Leben Co., Ltd. is a JP stock and trading under the symbol 8897.T
What is Takara Leben Co., Ltd. stock quote today ?
Takara Leben Co., Ltd. stock price is $435 today.
Is Takara Leben Co., Ltd. stock public?
Yes, Takara Leben Co., Ltd. is a publicly traded company.